The effect of PCSK9 immunization on the hepatic level of microRNAs associated with PCSK9/LDLR pathway.

Introduction MicroRNAs (miRNAs) are a class of gene expression epigenetic regulators that play roles in regulating genes involved in cholesterol homeostasis, including low-density lipoprotein receptor (LDLR) and PCSK9; therefore, miRNAs have been suggested as potential therapeutic targets for treati...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Archives of Medical Science
المؤلفون الرئيسيون:	Sarina Ataei, Shiva Ganjali, Maciej Banach, Ehsan Karimi, Amirhossein Sahebkar
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Termedia Publishing House 2023-01-01
الموضوعات:	atherosclerosis pcsk9 ldlr mirna
الوصول للمادة أونلاين:	https://www.archivesofmedicalscience.com/The-effect-of-PCSK9-immunization-on-the-hepatic-level-of-microRNAs-associated-with,152000,0,2.html

مواد مشابهة

A New Strategy for Rapidly Screening Natural Inhibitors Targeting the PCSK9/LDLR Interaction In Vitro
حسب: Li Li, وآخرون
منشور في: (2018-09-01)

Targeting PCSK9 as a key player in lipid metabolism: exploiting the therapeutic and biosensing potential of aptamers
حسب: Maryam Mahjoubin-Tehran, وآخرون
منشور في: (2024-05-01)

MiR-99a-5p up-regulates LDLR and functionally enhances LDL-C uptake via suppressing PCSK9 expression in human hepatocytes
حسب: Xuemei Chen, وآخرون
منشور في: (2024-11-01)

Dihydromyricetin promotes LDL metabolism in HepG2 cells through the PCSK9/LDLR pathway
حسب: Li-Tian Wang, وآخرون
منشور في: (2023-12-01)

PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs
حسب: Nikolay Kuzmich, وآخرون
منشور في: (2022-01-01)

Kratom leaf extracts exert hypolipidaemic effects via the modulation of PCSK9 and LDLR pathways in HepG2 cells
حسب: Nantiya Nawaka, وآخرون
منشور في: (2025-05-01)

Insights into PCSK9-LDLR Regulation and Trafficking via the Differential Functions of MHC-I Proteins HFE and HLA-C
حسب: Sepideh Mikaeeli, وآخرون
منشور في: (2024-05-01)

17β-Estradiol Inhibits PCSK9-Mediated LDLR Degradation Through GPER/PLC Activation in HepG2 Cells
حسب: Wei Fu, وآخرون
منشور في: (2020-01-01)

A Novel Small-Molecule GRP94 Modulator Increases PCSK9 Secretion and Promotes LDLR Degradation
حسب: Wenjing Yan, وآخرون
منشور في: (2025-08-01)

Insight into the Evolving Role of PCSK9
حسب: Mateusz Maligłówka, وآخرون
منشور في: (2022-03-01)

RETRACTED ARTICLE: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
حسب: Amir Abbas Momtazi-Borojeni, وآخرون
منشور في: (2019-12-01)

Identification of a novel LDLR p.Glu179Met variant in Thai families with familial hypercholesterolemia and response to treatment with PCSK9 inhibitor
حسب: Burabha Pussadhamma, وآخرون
منشور في: (2024-03-01)

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
حسب: Emma M. O’Connell, وآخرون
منشور في: (2020-06-01)

c-IAP1 Binds and Processes PCSK9 Protein: Linking the c-IAP1 in a TNF-α Pathway to PCSK9-Mediated LDLR Degradation Pathway
حسب: David Hornby, وآخرون
منشور في: (2012-10-01)

PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
حسب: Simon Rauterberg, وآخرون
منشور في: (2025-01-01)

Cholesterol-modulating effects of Korean red ginseng (KRG) targeting PCSK9 in hyperlipidemia
حسب: Chang Hwan Lee, وآخرون
منشور في: (2025-08-01)

Sex and racial differences in prevalence and clinical characteristics of people living with LDLR and PCSK9 familial hypercholesterolemia genetic variants: Data from the All of Us Research program
حسب: Jeffery Osei, وآخرون
منشور في: (2025-06-01)

High fat diet and PCSK9 knockout modulates lipid profile of the liver and changes the expression of lipid homeostasis related genes
حسب: Krisztina Németh, وآخرون
منشور في: (2023-03-01)

Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With Obesity
حسب: Chiara Macchi, وآخرون
منشور في: (2022-01-01)

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
حسب: A. Yu. Filatova, وآخرون
منشور في: (2019-06-01)

PCSK9 Inhibitors: Focus on Evolocumab and Its Impact on Atherosclerosis Progression
حسب: Maram H. Abduljabbar
منشور في: (2024-11-01)

Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
حسب: Łukasz Wołowiec, وآخرون
منشور في: (2023-01-01)

Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
حسب: Emily Punch, وآخرون
منشور في: (2022-02-01)

PCSK9 inhibitor failure in a statin-intolerant FH patient with a novel LDLR variant: a case report
حسب: Yuan Li, وآخرون
منشور في: (2025-09-01)

Carotenoid Interactions with PCSK9: Exploring Novel Cholesterol-Lowering Strategies
حسب: Alessandro Medoro, وآخرون
منشور في: (2024-11-01)

PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
حسب: Tóth Štefan, وآخرون
منشور في: (2020-08-01)

Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in an experimental mouse model
حسب: Amir Abbas Momtazi-Borojeni, وآخرون
منشور في: (2025-02-01)

Pterostilbene Increases LDL Metabolism in HL-1 Cardiomyocytes by Modulating the PCSK9/HNF1α/SREBP2/LDLR Signaling Cascade, Upregulating Epigenetic hsa-miR-335 and hsa-miR-6825, and LDL Receptor Expression
حسب: Yen-Kuang Lin, وآخرون
منشور في: (2021-08-01)

PCSK9: BIOLOGICAL ACTIVITY REGULATION AND CONNECTION WITH LIPID AND CARBOHYDRATE METABOLISM
حسب: A O Averkova
منشور في: (2017-09-01)

PCSK9 in T-cell function and the immune response
حسب: Yuying Wang, وآخرون
منشور في: (2024-12-01)

The Cholesterol-Modulating Effect of Methanol Extract of Pigeon Pea (<i>Cajanus cajan</i> (L.) Millsp.) Leaves on Regulating LDLR and PCSK9 Expression in HepG2 Cells
حسب: Heng-Yuan Chang, وآخرون
منشور في: (2019-01-01)

Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1
حسب: Mihir R. Atreya, وآخرون
منشور في: (2023-06-01)

Pre-Clinical Evaluation of the Nanoliposomal antiPCSK9 Vaccine in Healthy Non-Human Primates
حسب: Amir Abbas Momtazi-Borojeni, وآخرون
منشور في: (2021-07-01)

The association between circulatory, local pancreatic PCSK9 and type 2 diabetes mellitus: The effects of antidiabetic drugs on PCSK9
حسب: Fengyuan Lu, وآخرون
منشور في: (2023-09-01)

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) to tackle central nervous system diseases: role as a promising approach
حسب: Xiaoxiao Zheng, وآخرون
منشور في: (2025-07-01)

Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia
حسب: Piotr Pęczek, وآخرون
منشور في: (2021-05-01)

VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeys
حسب: Madeline M. Vroom, وآخرون
منشور في: (2024-02-01)

Correlation of PCSK9 and Serum sdLDL Levels and Other Demographic and Laboratory Indicators in Healthy Individuals
حسب: Reza Hosseini-Fard, وآخرون
منشور في: (2018-05-01)

Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer
حسب: Amir Abbas Momtazi-Borojeni, وآخرون
منشور في: (2019-04-01)

PCSK9 - A New and Potent Approach to Lowering Cholesterol
حسب: Thomas F. Whayne Jr.
منشور في: (2013-05-01)